Concepedia

Pjotr Knyazev

PK

Statistics

Publications

28

Citations

2.4K

H-Index

22

Active since

1995

Affiliations

Max Planck Institute of Biochemistry(Current)

Max Planck Society

Ludwig-Maximilians-Universität München

Institute of Molecular and Cell Biology

Technical University of Munich

Pjotr Knyazev is an author at Max Planck Institute of Biochemistry specializing in oncology, medicine, and cancer cell signaling.

Publications per year

1995–2017

28

Publications

28

Structural basis for Gas6–Axl signalling

Takako Sasaki, Pjotr Knyazev, Naomi J. Clout et al. · The EMBO Journal · 2005 · 292 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +12

Axl and Growth Arrest–Specific Gene 6 Are Frequently Overexpressed in Human Gliomas and Predict Poor Prognosis in Patients with Glioblastoma Multiforme

Markus Hutterer, Pjotr Knyazev, Ariane Abate et al. · Clinical Cancer Research · 2008 · 277 citations

Medicine, Cancer Biology, Oncology +17

Mig6 is a negative regulator of EGF receptor–mediated skin morphogenesis and tumor formation

Ingvar Ferby, Markus Reschke, Oliver Kudlacek et al. · Nature Medicine · 2006 · 265 citations

Life Sciences, Cell Biology, Developmental Biology +17

Dominant-negative inhibition of the Axl receptor tyrosine kinase suppresses brain tumor cell growth and invasion and prolongs survival

Peter Vajkoczy, Pjotr Knyazev, Andrea Kunkel et al. · Proceedings of the National Academy of Sciences · 2006 · 236 citations · Full text

Medicine, Cancer Biology, Oncology +17

HER3 Is a Determinant for Poor Prognosis in Melanoma

Markus Reschke, Daniela Mihic‐Probst, Edward H. van der Horst et al. · Clinical Cancer Research · 2008 · 166 citations · Full text

Medicine, Cancer Biology, Oncology +17

1–5 of 28